Class Action Lawsuit Filed Against Tenax Therapeutics
Investors have initiated a class action lawsuit against Tenax Therapeutics, alleging securities law violations between November 2023 and August 2026.
Law firm Bronstein Gewirtz & Grossman has filed a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) on behalf of investors who purchased securities between November 13, 2023, and August 7, 2026. The action seeks damages for alleged financial losses incurred during this period.
The complaint alleges that the company disseminated misleading information to the market, potentially impacting the stock's valuation. Investors seeking to participate in the class action are required to meet a court-appointed deadline of December 28, 2026.
This litigation highlights increasing scrutiny regarding the company’s disclosures during the specified timeframe. Legal proceedings will determine whether the allegations have merit and whether compensation for affected shareholders is warranted.